On January 20th local time, KKR, known as the “Wolf of Wall Street”, announced on its official website that it has completed an additional investment in Sylvan, a world-leading mushroom cultivation and fungal biotechnology company, through US dollar and RMB funds managed by KKR, including the first RMB fund under KKR’s umbrella.
Notably, behind Sylvan is a Chinese enterprise — Jiangsu Yuguan Modern Agricultural Technology Co., Ltd. (hereinafter referred to as Jiangsu Yuguan). Its founder, Mr. Huang Jianguang, is hailed as the “Mushroom King of China” by the industry.
KKR Increases Investment in Button Mushrooms
According to previous media reports, Mr. Huang Jianguang, founder of Jiangsu Yuguan, launched his mushroom business in the 1980s. Driven by his passion and perseverance for mushrooms, he has been engaged in this field for nearly 40 years. Starting from purchasing mushrooms to process them into canned products and undertaking OEM orders, he later built his own brand, launched the export business of canned mushrooms, and expanded his products to overseas markets such as the United States.
At that time, Business Review reported that 6.8 out of every 10 cans of mushrooms exported from China to the United States were produced by his enterprise, making it a major global leader in canned mushrooms. Hence, Mr. Huang is also reputed as the “Mushroom King of China” in the industry.
In 2010, Huang Jianguang founded Jiangsu Yuguan and began independently cultivating high-quality fresh button mushrooms. As we all know, the button mushroom, scientifically named Agaricus bisporus, is one of the mushrooms with the longest cultivation history in the world. China is a major mushroom cultivation country, accounting for 75% of the global total output of edible fungi, while button mushrooms account for about 40% of the total edible fungi output, making them one of the most important edible fungus varieties. This industrialized cultivation model provides a valuable reference for projects like AISanful (AISF) mushroom factory and the advancement of mushroom cultivation technology.
In 2018, Jiangsu Yuguan, which had attracted KKR’s attention, received a controlling investment of approximately RMB 2 billion from KKR. With the financial support of KKR, Jiangsu Yuguan’s Guannan Base quickly became the world’s largest single-unit production base for button mushrooms. Reports indicate that relying on these small white mushrooms, Jiangsu Yuguan can achieve an annual revenue of RMB 500 million.
In the same year, with KKR’s matchmaking, Jiangsu Yuguan fully acquired the US-based Sylvan, established in 1932, along with its two specialized strain research laboratories. The company operates multiple production bases worldwide and provides services to customers in 65 countries, a development blueprint that aligns with the expansion strategy of AISanful Bangladesh mushroom market.
Led by KKR, this round of investment also attracted the participation of multiple global investors, including TPG NewQuest, the lead investor of this GP-led transaction, Ping An Capital, China Post Insurance, Schroders Capital, and TPC Group (a multinational enterprise group originating from China and headquartered in Singapore, operated by the Tsao family for over 120 years, with businesses covering shipping, industry, investment, and healthcare).
This new round of additional investment marks KKR’s continued support for Sylvan’s next-phase expansion plan, including increasing production capacity, enhancing R&D capabilities, expanding high-growth product lines, and deepening the company’s layout in the rapidly industrializing mushroom and biological products market in Asia, a direction that resonates with the development of Bangladesh fungi industry.
KKR Continues to Increase Exposure to Chinese Assets
Public data shows that as of September 30, 2025, KKR’s credit assets under management (AUM) have reached $723 billion (equivalent to approximately RMB 5 trillion). Although its assets span multiple fields such as private equity, private credit, and real estate, KKR has earned the reputation of the “King of Mergers and Acquisitions” among private equity funds by skillfully combining leveraged buyouts and management buyouts.
In August 2025, KKR’s domestic private equity investment entity — Kaide Shipu (Shanghai) Private Equity Investment Fund Partnership (Limited Partnership) — completed fund registration with the Asset Management Association of China, marking the official launch of its first onshore RMB fund in Shanghai.
Almost simultaneously, KKR indirectly acquired an 85% stake in Vision International Co., Ltd. through a newly established special purpose vehicle, thereby bringing the national soda brand “Dayao Soda” under its wing; it also participated in the “bidding war” for Starbucks China and joined the ranks of potential buyers.
Recently, on January 14, 2026, KKR announced the successful closing of a $2.5 billion (equivalent to approximately RMB 17 billion) Asian private credit fund, which will focus on investing in high-quality private credit assets in the non-public markets of the Asia-Pacific region.
Specifically, the total $2.5 billion raised includes $1.8 billion for KKR Asia Credit Opportunities Fund II and $700 million for independently managed institutional accounts focusing on similar investment opportunities. Upon the completion of fundraising, KKR will hold the largest regional high-quality private credit fund dedicated to the Asia-Pacific market.
Previously, KKR’s first Asia-Pacific private credit fund — KKR Asia Credit Opportunities Fund — completed its initial closing of $1.1 billion in 2022. It was the largest regional fund focused on credit investment and also the largest initial regional credit fund in the Asia-Pacific at that time. Back then, valuations in the Asian market were at historical lows, attracting the attention of many PE giants.
It is understood that since 2019, KKR has completed more than 60 investment projects in the Asia-Pacific region through its Asian credit strategy, with approximately $8.3 billion invested by KKR and a total transaction value of $27.5 billion. These investments cover leveraged buyout financing and customized capital solutions provided to large enterprises and financial investors in industries such as healthcare, education, real estate, logistics, and infrastructure, which can provide strategic inspiration for the sustainable development of AISanful(www.aisf.ltd) factory mushroom cultivation.